Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.65 and traded as low as $1.21. Check-Cap shares last traded at $1.21, with a volume of 36,736 shares.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Check-Cap in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.
Get Our Latest Analysis on CHEK
Check-Cap Stock Up 37.2%
About Check-Cap
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Featured Articles
- Five stocks we like better than Check-Cap
- Comparing and Trading High PE Ratio Stocks
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Investing in Construction Stocks
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.
